T. Naib

Lenalidomide‐induced myelosuppression is associated with renal dysfunction: adverse events evaluation of treatment‐naïve patients undergoing front‐line lenalidomide and dexamethasone therapy

J. Leonard, M. Mazumdar, S. Ely, 2007, British journal of haematology.

PALLIATIVE CARE IN THE CARDIAC INTENSIVE CARE UNIT

U. Gidwani, S. Arora, S. Lahewala, 2014 .

Palliative care in the cardiac intensive care unit.

U. Gidwani, S. Arora, S. Lahewala, 2015, The American journal of cardiology.

BiRD (Biaxin [clarithromycin]/Revlimid [lenalidomide]/dexamethasone) combination therapy results in high complete- and overall-response rates in treatment-naive symptomatic multiple myeloma.

J. Leonard, M. Mazumdar, S. Ely, 2008, Blood.

Echocardiography in functional midgut neuroendocrine tumors: When and how often

D. Adams, J. Castillo, Jerome S. Zacks, 2017, Reviews in Endocrine and Metabolic Disorders.

Cardiac magnetic resonance evaluation of left ventricular remodelling distribution in cardiac amyloidosis

V. Fuster, M. Cham, J. Sanz, 2014, Heart.

BiRD (Biaxin [clarithromycin]/Revlimid [lenalidomide]/dexamethasone) combination therapy results in high complete- and overall-response rates in treatment-naive symptomatic multiple myeloma.

J. Leonard, M. Mazumdar, S. Ely, 2008, Blood.

BiRD (Biaxin [clarithromycin]/Revlimid [lenalidomide]/dexamethasone) combination therapy results in high complete- and overall-response rates in treatment-naive symptomatic multiple myeloma.

J. Leonard, M. Mazumdar, S. Ely, 2008, Blood.